FTI Consulting, Inc.
NYSE:FCNConsulting Services
-$6.58 today
- Market cap
- $5.63B
- Beta
- -0.05
- P/E (TTM)
- 17.0
- EPS (TTM)
- $8.47
Volume 0.44M
Average 0.47M
FCN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
FTI Consulting, Inc.NYSE: FCN
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FCN compares with its peers on the latest reported figures
- FCN's LTM Jun 2026 research & development of $0 is the 4th highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for FCN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
RALRalliant Corp. | LTM Oct 2026 | $173.8M | +5.8% | +2.1% | 7.6% |
| LTM Jun 2026 | $71.9M | — | — | 2.1% | |
| LTM Sep 2026 | $71.63M | +8.5% | +4.7% | 3.6% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding FCN) | $0 | +7.2% | +3.4% | 0.0% | |
Competitors are the stored peer set for FCN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.78B | 3.03B | 3.49B | 3.7B | 3.79B |
| Cost of Revenue | 1.92B | 2.07B | 2.35B | 2.52B | 2.57B |
| Gross Profit | 860.72M | 962.93M | 1.14B | 1.18B | 1.22B |
| Gross Margin | 31.0% | 31.8% | 32.5% | 32.0% | 32.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 537.84M | 641.07M | 751.31M | 822.15M | 799.62M |
| Operating Expenses | 548.67M | 659.05M | 757.47M | 834.56M | 803.1M |
| Depreciation & Amortization | 45.09M | 45.54M | 47.24M | 48.09M | 49.24M |
| EBITDA | 363.33M | 353.34M | 419.93M | 405.82M | 441.65M |
| EBITDA Margin | 13.1% | 11.7% | 12.0% | 11.0% | 11.7% |
| Operating Income | 312.05M | 303.88M | 377.56M | 347.36M | 414.37M |
| Operating Margin | 11.2% | 10.0% | 10.8% | 9.4% | 10.9% |
| Interest Income | 2.43M | 4.62M | 5.21M | 8.47M | 7.06M |
| Interest Expense | 20.29M | 10.05M | 14.33M | 6.95M | 21.4M |
| Other Income / Expenses | (14.1M) | (6.13M) | (19.2M) | 3.41M | (43.36M) |
| Income Before Tax | 297.95M | 297.75M | 358.36M | 350.77M | 371.01M |
| Pre-Tax Margin | 10.7% | 9.8% | 10.3% | 9.5% | 9.8% |
| Income Tax Expense | 62.98M | 62.24M | 83.47M | 70.68M | 100.14M |
| Net Income | 234.97M | 235.51M | 274.89M | 280.09M | 270.87M |
| Net Margin | 8.5% | 7.8% | 7.9% | 7.6% | 7.1% |
| EPS (Basic) | 7.02 | 6.99 | 8.10 | 7.96 | 8.33 |
| EPS (Diluted) | 6.65 | 6.58 | 7.71 | 7.81 | 8.24 |
| Weighted Avg Shares | 33.49M | 33.69M | 33.92M | 35.21M | 32.53M |
| Weighted Avg Shares (Diluted) | 35.34M | 35.78M | 35.65M | 35.85M | 32.88M |
FTI Consulting, Inc.
NYSE:FCN
Intrinsic Alpha fair value
Locked
Current Price
$206.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.